title: Characterization of variegate porphyria mutations using a minigene approach.
abstract: Porphyrias are a group of metabolic diseases that affect the skin and/or nervous system. In 2008, three unrelated patients were diagnosed with variegate porphyria at the CIPYP (Centro de Investigaciones sobre Porfirinas y Porfirias). Sequencing of the protoporphyrinogen oxidase gene, the gene altered in this type of porphyria, revealed three previously undescribed mutations: c.338+3insT, c.807G>A, and c.808-1G>C. As these mutations do not affect the protein sequence, we hypothesized that they might be splicing mutations. RT-PCRs performed on the patient's mRNAs showed normal mRNA or no amplification at all. This result indicated that the aberrant spliced transcript is possibly being degraded. In order to establish whether they were responsible or not for the patient's disease by causing aberrant splicing, we utilized a minigene approach. We found that the three mutations lead to exon skipping; therefore, the abnormal mRNAs are most likely degraded by a mechanism such as nonsense-mediated decay. In conclusion, these mutations are responsible for the disease because they alter the normal splicing pathway, thus providing a functional explanation for the appearance of disease and highlighting the use of minigene assays to complement transcript analysis.
authors: Centro de Investigaciones sobre Porfirinas y Porfirias, Hospital de Clínicas José de San Martín, CONICET, Buenos Aires, Argentina.
authors: Barbara Xoana
authors: BX
authors: Granata
authors: Marco
authors: M
authors: Baralle
authors: Laura
authors: L
authors: De Conti
authors: Victoria
authors: V
authors: Parera
authors: Maria Victoria
authors: MV
authors: Rossetti
references: J Invest Dermatol. 1998 Apr;110(4):452-5
references: 9540991
references: Hum Mol Genet. 1998 Nov;7(12):1921-5
references: 9811936
references: Br J Dermatol. 2006 Feb;154(2):368-71
references: 16433813
references: Nat Rev Mol Cell Biol. 2004 Feb;5(2):89-99
references: 15040442
references: Science. 2002 Aug 9;297(5583):1007-13
references: 12114529
references: EMBO Rep. 2009 Aug;10(8):810-6
references: 19648957
references: J Comput Biol. 1997 Fall;4(3):311-23
references: 9278062
references: Br J Dermatol. 2001 Apr;144(4):866-9
references: 11298551
references: Postgrad Med J. 1993 Oct;69(816):781-6
references: 8290408
references: J Invest Dermatol. 2001 Apr;116(4):610-3
references: 11286631
references: Lancet. 2005 Jan 15-21;365(9455):241-52
references: 15652607
references: J Biol Chem. 1995 Apr 7;270(14):8076-80
references: 7713909
references: Clin Exp Dermatol. 2013 Oct;38(7):737-40
references: 24073655
references: Hum Mol Genet. 1998 May;7(5):919-32
references: 9536098
references: Intern Emerg Med. 2010 Oct;5 Suppl 1:S65-71
references: 20865477
references: Hum Mol Genet. 1995 Dec;4(12):2387-90
references: 8634714
references: Nat Genet. 2002 Apr;30(4):426-9
references: 11889466
references: Genomics. 1995 Oct 10;29(3):698-703
references: 8575762
references: Hum Genet. 1981;58(4):425-8
references: 7327566
references: Nucleic Acids Res. 2003 Jul 1;31(13):3568-71
references: 12824367
references: Biochem Biophys Res Commun. 1996 Sep 4;226(1):226-30
references: 8806618
references: BMC Med Genet. 2008 Jun 20;9:54
references: 18570668
references: Mol Genet Metab. 2000 Apr;69(4):323-30
references: 10870850
references: Eur J Dermatol. 2006 May-Jun;16(3):230-40
references: 16709484
references: J Med Genet. 2005 Oct;42(10):737-48
references: 16199547
references: Lancet. 2010 Mar 13;375(9718):924-37
references: 20226990
references: Hum Mol Genet. 2006 Aug 15;15(16):2490-508
references: 16825284